探索化疗患者的想法,需求和恐惧 - - 基于谷歌搜索行为分析
Deniz Özistanbullu1, Ronja Weber1, Maria Schröder2
1Department of Dermatology, Venereology and Allergology, University Hospital Frankfurt, Goethe University, 60596 Frankfurt, Germany.
Healthcare (Basel, Switzerland)
|September 14, 2024
概括
患者经常在网上搜索化疗信息,显示出对副作用的担忧,如脱发和与免疫疗法潜在的混. 了解这些搜索有助于医疗保健提供者提供更好的以患者为中心的护理.
科学领域:
- 在瘤学瘤学.
- 医疗信息学 医疗信息学
- 数字健康数字健康
背景情况:
- 患者在化疗期间面临着重大的身体和心理挑战.
- 在线资源是寻求独立健康信息的患者的主要来源.
- 了解患者在线搜索行为对于解决他们的需求至关重要.
研究的目的:
- 分析2018年9月至2022年9月,与化疗相关的德国谷歌搜索趋势.
- 为了识别患者的担忧,信息需求,以及化学疗法的潜在困惑问题.
- 为医疗保健提供者提供见解,以加强以患者为中心的护理.
主要方法:
- 利用谷歌AdWords数据在德国寻找与化疗相关的搜索术语.
- 在四年内分析了1461个独特的搜索术语.
- 按频率和内容分类搜索查询.
主要成果:
- 乳腺癌是最常被搜索的瘤类型.
- 脱发和相关的皮肤问题是最常见的副作用搜索.
- 搜索"辅助剂"",新辅助剂"化疗和"免疫疗法"表明潜在的患者困惑.
结论:
- 谷歌搜索为患者的担忧和化疗期间的信息缺口提供了有价值的见解.
- 识别特定的患者需求,比如管理脱发,可以告知有针对性的支持.
- 医疗保健提供者可以使用搜索数据来定制沟通和改善治疗结果.
相关概念视频
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Nursing Ethical Principles II
934
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
934
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
181
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
181
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
154
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
154


